Private Trust Co. NA Sells 3,567 Shares of Omega Healthcare Investors, Inc. $OHI

Private Trust Co. NA reduced its stake in Omega Healthcare Investors, Inc. (NYSE:OHI) by 55.6% during the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 2,851 shares of the real estate investment trust’s stock after selling 3,567 shares during the period. Private Trust Co. NA’s holdings in Omega Healthcare Investors were worth $104,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds have also modified their holdings of OHI. AQR Capital Management LLC boosted its stake in Omega Healthcare Investors by 430.8% in the 1st quarter. AQR Capital Management LLC now owns 2,862,117 shares of the real estate investment trust’s stock valued at $108,989,000 after buying an additional 2,322,878 shares in the last quarter. Vanguard Group Inc. grew its holdings in shares of Omega Healthcare Investors by 3.9% in the 1st quarter. Vanguard Group Inc. now owns 39,554,886 shares of the real estate investment trust’s stock worth $1,506,250,000 after purchasing an additional 1,492,904 shares during the last quarter. Invesco Ltd. grew its holdings in shares of Omega Healthcare Investors by 122.3% in the 1st quarter. Invesco Ltd. now owns 2,416,560 shares of the real estate investment trust’s stock worth $92,023,000 after purchasing an additional 1,329,324 shares during the last quarter. Nuveen LLC acquired a new stake in shares of Omega Healthcare Investors during the 1st quarter worth about $42,513,000. Finally, Allspring Global Investments Holdings LLC lifted its holdings in Omega Healthcare Investors by 556.1% during the 1st quarter. Allspring Global Investments Holdings LLC now owns 1,028,187 shares of the real estate investment trust’s stock valued at $39,143,000 after purchasing an additional 871,472 shares during the last quarter. 65.25% of the stock is owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

OHI has been the subject of several recent analyst reports. Truist Financial raised their price objective on shares of Omega Healthcare Investors from $39.00 to $44.00 and gave the stock a “hold” rating in a report on Wednesday, September 3rd. Wells Fargo & Company lifted their price objective on Omega Healthcare Investors from $44.00 to $45.00 and gave the company an “overweight” rating in a research report on Tuesday. Mizuho increased their target price on Omega Healthcare Investors from $37.00 to $40.00 and gave the stock a “neutral” rating in a report on Thursday, September 11th. Raymond James Financial reaffirmed an “outperform” rating on shares of Omega Healthcare Investors in a report on Tuesday, September 2nd. Finally, Weiss Ratings reissued a “buy (b)” rating on shares of Omega Healthcare Investors in a report on Wednesday, October 8th. Six investment analysts have rated the stock with a Buy rating and five have issued a Hold rating to the stock. Based on data from MarketBeat, Omega Healthcare Investors has a consensus rating of “Moderate Buy” and a consensus price target of $44.50.

Insiders Place Their Bets

In other Omega Healthcare Investors news, Director Lisa Egbuonu-Davis sold 2,500 shares of the firm’s stock in a transaction that occurred on Friday, August 8th. The shares were sold at an average price of $40.16, for a total value of $100,400.00. Following the transaction, the director directly owned 18,654 shares of the company’s stock, valued at approximately $749,144.64. This trade represents a 11.82% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. 1.50% of the stock is owned by corporate insiders.

Omega Healthcare Investors Trading Up 0.7%

Shares of OHI opened at $40.62 on Thursday. The stock’s fifty day simple moving average is $41.60 and its 200-day simple moving average is $38.94. The firm has a market capitalization of $11.98 billion, a PE ratio of 25.07, a price-to-earnings-growth ratio of 1.88 and a beta of 0.70. Omega Healthcare Investors, Inc. has a 12-month low of $35.04 and a 12-month high of $44.42. The company has a quick ratio of 7.10, a current ratio of 7.10 and a debt-to-equity ratio of 0.96.

Omega Healthcare Investors (NYSE:OHI) last announced its quarterly earnings data on Thursday, July 31st. The real estate investment trust reported $0.77 EPS for the quarter, topping analysts’ consensus estimates of $0.45 by $0.32. Omega Healthcare Investors had a return on equity of 9.78% and a net margin of 42.23%.The firm had revenue of $235.60 million during the quarter, compared to analyst estimates of $248.49 million. During the same period last year, the company earned $0.71 earnings per share. The company’s revenue was up 11.8% on a year-over-year basis. Omega Healthcare Investors has set its FY 2025 guidance at 3.040-3.070 EPS. As a group, research analysts predict that Omega Healthcare Investors, Inc. will post 2.86 earnings per share for the current year.

Omega Healthcare Investors Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Friday, August 15th. Investors of record on Monday, August 4th were issued a $0.67 dividend. This represents a $2.68 annualized dividend and a yield of 6.6%. The ex-dividend date was Monday, August 4th. Omega Healthcare Investors’s dividend payout ratio is currently 165.43%.

Omega Healthcare Investors Company Profile

Omega Healthcare Investors, Inc engages in the provision of financing and capital to the long-term healthcare industry with a particular focus on skilled nursing facilities, assisted living facilities, independent living facilities, rehabilitation and acute care facilities, and medical office buildings.